期刊文献+

Foxp3+调节性T细胞与心肌缺血再灌注损伤概述

Overview of Foxp3+ Regulatory T Cells and Myocardial Ischemia Reperfusion Injury
下载PDF
导出
摘要 心肌缺血再灌注损伤与心肌梗死的面积密切相关,减少心肌缺血再灌注损伤有助于改善心肌梗死患者的预后。炎症在心肌缺血再灌注损伤中发挥重要作用。及时消除炎症渗入,将炎症反应和修复反应在空间上限制在心肌梗死区,是实现梗死区最佳愈合的关键。Foxp3+调节性T细胞参与调节各种生理和病理的免疫炎症反应。心肌梗死后,Foxp3+调节性T细胞可促进心肌组织的再生和修复,加速心肌梗死的恢复过程。现系统综述Foxp3+调节性T细胞在心肌缺血再灌注损伤中的作用,旨在深入了解Foxp3+调节性T细胞的功能,这可能有助于设计有效的方法来控制免疫反应,为心肌梗死提供新的潜在治疗方案。 The final area of myocardial infarction is closely related to myocardial ischemia reperfusion injury.Reducing myocardial ischemia reperfusion injury can improve the prognosis of myocardial infarction patients.Inflammation plays an important role in myocardial ischemia reperfusion injury.Timely elimination of inflammatory infiltration and spatially limiting the inflammatory and reparative reactions to the myocardial infarction area is the key to achieving optimal healing of the infarction area.Foxp3+ regulatory T cells participate in regulating various physiological and pathological immune-inflammatory reactions.After myocardial infarction,Foxp3+ regulatory T cells can promote the regeneration and repair of myocardial tissue,accelerating the healing process of myocardial infarction.This article provides a systematic review of the role of Foxp3+ regulatory T cells in myocardial ischemia reperfusion injury,aiming to deepen our understanding of their functions.This may help design effective methods to control immune reactions and provide new potential treatment options for myocardial infarction.
作者 李俊霖 韩虎魁 程攀科 李刚 陶剑虹 LI Junlin;HAN Hukui;CHENG Panke;LI Gang;TAO Jianhong(School of Medicine,University of Electronic Science and Technology of China,Chengdu 611731,Sichuan,China;Department of Cardiology,The Affiliated Hospital of University of Electronic Science and Technology of China,Sichuan Academy of Medical Sciences&Sichuan Provincial People’s Hospital,Chengdu 610072,Sichuan,China)
出处 《心血管病学进展》 CAS 2023年第9期832-836,共5页 Advances in Cardiovascular Diseases
基金 国家自然科学基金(32000967) 四川省自然科学基金(2022NSFSC0817,2022NSFSC0811,23NSFSC1540,23NSFSC1541) 四川省人民医院基金(2020QN01) 四川省干部保健科研项目(川干保ZH2022-201) 成都市重点研发支撑计划重大科技应用示范项目(2021-YF09-00033-SN)。
关键词 调节性T细胞 心肌缺血再灌注损伤 FOXP3 免疫反应 Regulatory T cell Myocardial ischemia reperfusion injury Foxp3 Immune response
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部